Pfizer, Servier Enter into Exclusive Global License, Collaboration Agreement to Co-develop and Commercialize UCART19
November 19, 2015 at 04:24 AM EST
Cellectis (Nasdaq: CLLS) and Servier today announced that they signed an amendment to their existing collaboration ...
